Thus, miR-196 appear to fine-tune the invasion mechanism in oral cancer by inhibiting NME4, leading to the activation of p-JNK and MMP1/9 and suppression of TIMP1 (Figure 4C). Here, NME4 is linked to lip and oral cavity carcinoma.